Covid Vaccine: Bharat Biotech will launch its intranasal Kovid-19 vaccine INCOVACC on 26 January. Company’s CMD Krishna Ella announced this on Saturday. The vaccine maker had already received approval for the nasal vaccine from the Central Drugs Standard Control Organization (CDSCO) earlier this month. Which is the first such vaccine in India.
What Krishna Illa said
Illa said while participating in a session during the 8th edition of the India International Science Festival (IISF) that began at Maulana Azad National Institute of Technology (MANIT) – Our nasal vaccine will be officially launched on 26th January on Republic Day. The session was titled ‘Face-to-Face with New Frontiers in Science’.
The company had earlier announced this
The company had earlier announced that it would price the intranasal vaccine at Rs 325 per shot for government procurement and Rs 800 per shot for private vaccination centres. Will keep According to the vaccine manufacturer, the nasal mucosa has excellent immunogenicity due to its organized immune system.
Thus, intranasal vaccination of CHAD-SARS-CoV-2-S may induce an immune response in the nose, which is the point of entry for the virus, thereby protecting against disease, infection, and transmission.
< p>How is it used?
The nasal vaccine will be given through the nose instead of being applied to the arm. In all the research that has been done so far, it has been revealed that the corona makes a place in the body through the nose itself. In such a situation, if this vaccine is given through the nose, then it will prove to be very effective. Recently, another thing came to light regarding this that the nasal vaccine will not be given to those people who have already got booster dose. This information was given by Dr. NK Arora, head of the country’s vaccine task force.